Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMRN | Amarin Corporation Plc Sponsored ADR | 1.32% | 18.39 | 1.8% | $132.24m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 4.05% | 90.53 | 18.6% | $94.99m | |
| SAGE | SAGE Therapeutics, Inc. | 0.89% | 166.98 | 8.8% | $82.15m | |
| JAZZ | Jazz Pharmaceuticals Plc | 3.03% | 129.78 | 2.3% | $71.68m | |
| GWPH | GW Pharmaceuticals PLC Sponsored ADR | 2.21% | 165.56 | 6.3% | $60.71m | |
| PRGO | Perrigo Co. Plc | 1.21% | 49.56 | 6.8% | $54.61m | |
| ZGNX | Zogenix, Inc. | 0.48% | 37.39 | 9.9% | $45.65m | |
| UTHR | United Therapeutics Corporation | 5.53% | 104.31 | 14.3% | $44.47m | |
| CTLT | Catalent Inc | 0.91% | 44.44 | 2.4% | $39.76m | |
| HZNP | Horizon Pharma plc | 2.98% | 25.26 | 6.7% | $35.55m | |
| PTLA | Portola Pharmaceuticals, Inc. | 2.76% | 35.40 | 7.6% | $33.06m | |
| ICLR | ICON Plc | 3.89% | 135.05 | 4.1% | $30.66m | |
| ZYNE | Zynerba Pharmaceuticals Inc | 4.21% | 9.90 | 8.3% | $28.70m | |
| MYOK | MyoKardia, Inc. | 2.06% | 49.07 | 2.4% | $25.77m | |
| MNK | Mallinckrodt Plc | 3.15% | 18.36 | 21.0% | $25.24m |
Company Profile
Zogenix, Inc. is a pharmaceutical compan. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.